How bad are bacteremia and sepsis? Outcomes in a cohort with suspected bacteremia.

BACKGROUND To evaluate the short-term and long-term outcomes of patients with suspected bacteremia, we performed a prospective cohort study. METHODS Clinical data were collected within 24 hours of initial culture from a random sample of 1516 episodes in which blood cultures were performed in an urban tertiary care hospital. One hundred forty-two patients with bacteremia were compared with two comparison groups: (1) 142 randomly selected patients with negative cultures, matched in age within 5 years, gender, severity of underlying disease, and presence of major comorbidity, and (2) all 155 patients with contaminant cultures. The main outcome measures were death, death secondary to bacteremia, and major complications. RESULTS In the 439 patients, there were 142 deaths (32%), 114 at 1 year (26%) and 46 within 30 days (11%). Mortality at 30 days was most highly correlated with predicted fatality of underlying disease: 48% for the 65 patients with a rapidly fatal disease, 9% for the 156 patients with an eventually fatal disease, and 0.5% for the 217 patients with no fatal disease. In a Cox survival analysis, the risk ratio associated with bacteremia was 1.6 (95% confidence interval, 1.0 to 2.4) vs the comparison groups. When we performed time-dependent Cox analyses in which the hazard ratio was allowed to change at 30 days, we found that the risk ratios associated with bacteremia were 2.3 (95% confidence interval, 1.2 to 4.4) for the first 30 days, and 1.3 (95% confidence interval, 0.76 to 2.1) after 30 days. CONCLUSIONS We conclude that this population has a high mortality, which is strongly correlated with severity of underlying disease. Short-term mortality was higher in patients with bacteremia even after controlling for severity of illness, but the increase in risk was present only during the first month and most deaths occurred in patients with a rapidly fatal disease.

[1]  D. F. Fayed,et al.  Septic shock in critically ill patients: aetiology, management and outcome. , 1993, The Journal of infection.

[2]  R. Bone,et al.  Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome) , 1992, JAMA.

[3]  H. Aubé,et al.  Risk factors for septic shock in the early management of bacteremia. , 1992, The American journal of medicine.

[4]  D W Bates,et al.  Rapid classification of positive blood cultures. Prospective validation of a multivariate algorithm. , 1992, JAMA.

[5]  N. Engleberg,et al.  Anaerobic bacteremia: incidence, patient characteristics, and clinical significance. , 1992, The American journal of medicine.

[6]  D. Nash,et al.  Monoclonal antibodies for septic shock: in or out of the barn door? , 1991, QRB. Quality review bulletin.

[7]  Jerome J. Schentag,et al.  A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis , 1991 .

[8]  M. A. Martin,et al.  A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. , 1991, JAMA.

[9]  C. Sprung,et al.  Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. , 1991 .

[10]  L Goldman,et al.  Contaminant blood cultures and resource utilization. The true consequences of false-positive results. , 1991, JAMA.

[11]  E. Cook,et al.  Predicting bacteremia in hospitalized patients. A prospectively validated model. , 1990, Annals of internal medicine.

[12]  R. Wenzel,et al.  Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study. , 1989, American journal of infection control.

[13]  T. Clemmer,et al.  Sepsis syndrome: a valid clinical entity , 1989 .

[14]  A L Brannen,et al.  Prediction of outcome from critical illness. A comparison of clinical judgment with a prediction rule. , 1989, Archives of internal medicine.

[15]  M. A. Martin,et al.  Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. , 1989, Annals of internal medicine.

[16]  R F Woolson,et al.  Hospital-acquired candidemia. The attributable mortality and excess length of stay. , 1988, Archives of internal medicine.

[17]  J. Gatell,et al.  Pseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodes. , 1988, Reviews of infectious diseases.

[18]  T. Clemmer,et al.  Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. , 1987, Chest.

[19]  T. Sharpe,et al.  Prognostic indicators of septicaemia--a two year prospective evaluation. , 1987, Postgraduate medical journal.

[20]  R. Wenzel,et al.  Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. , 1987, The Journal of infectious diseases.

[21]  M R Harvey,et al.  A simple index to identify occult bacterial infection in adults with acute unexplained fever. , 1987, Archives of internal medicine.

[22]  D. Ilstrup,et al.  Blood cultures: issues and controversies. , 1986, Reviews of infectious diseases.

[23]  H. Sox,et al.  Clinical prediction rules. Applications and methodological standards. , 1985, The New England journal of medicine.

[24]  J. McCue Improved mortality in gram-negative bacillary bacteremia. , 1985, Archives of internal medicine.

[25]  R. Wenzel,et al.  Hospital-acquired bloodstream infections with Staphylococcus epidermidis. Review of 100 cases. , 1984, The American journal of medicine.

[26]  M. Weinstein,et al.  The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. , 1983, Reviews of infectious diseases.

[27]  W. R. Mccabe,et al.  Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. , 1980, The American journal of medicine.

[28]  P. Gross,et al.  Bacteremia in a community hospital: spectrum and mortality. , 1977, Archives of internal medicine.

[29]  A. Chow,et al.  Bacteroidaceae bacteremia: clinical experience with 112 patients. , 1974, Medicine.

[30]  A. Medeiros,et al.  Recent experience with bacillemia due to gram-negative organisms. , 1971, The Journal of infectious diseases.

[31]  K. Vosti,et al.  The importance of underlying disease in patients with gram-negative bacteremia. , 1968, Archives of internal medicine.

[32]  G. Jackson,et al.  Gram-Negative Bacteremia: I. Etiology and Ecology , 1962 .